Integrated Biopharma Changes Auditors
Ticker: INBP · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1016504
| Field | Detail |
|---|---|
| Company | Integrated Biopharma Inc (INBP) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, 8-k
TL;DR
IBP switches auditors to Citrin Cooperman & Company, LLP, effective April 22, 2025.
AI Summary
Integrated Biopharma, Inc. filed an 8-K on April 24, 2025, to report changes in its certifying accountant. The company previously engaged WithumSmith+Brown, PC, but has now appointed Citrin Cooperman & Company, LLP as its new independent registered public accounting firm. This change is effective as of April 22, 2025.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.
Risk Assessment
Risk Level: low — This filing solely concerns a change in the company's independent auditor, which is a routine administrative event.
Key Players & Entities
- Integrated Biopharma, Inc. (company) — Registrant
- April 24, 2025 (date) — Filing Date
- WithumSmith+Brown, PC (company) — Former Certifying Accountant
- Citrin Cooperman & Company, LLP (company) — New Certifying Accountant
- April 22, 2025 (date) — Effective Date of New Accountant
FAQ
Who was Integrated Biopharma's previous certifying accountant?
Integrated Biopharma's previous certifying accountant was WithumSmith+Brown, PC.
Who is Integrated Biopharma's new independent registered public accounting firm?
Integrated Biopharma's new independent registered public accounting firm is Citrin Cooperman & Company, LLP.
When did the change in certifying accountant become effective?
The change in certifying accountant became effective as of April 22, 2025.
What type of filing is this for Integrated Biopharma?
This is a Form 8-K filing, reporting current information.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report changes in the registrant's certifying accountant.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding INTEGRATED BIOPHARMA INC (INBP).